首页|期刊导航|郑州大学学报(医学版)|松油烯-4-醇通过调控SIRT1/FOXO1信号通路对慢性肾病小鼠肾小管上皮-间质转化的影响

松油烯-4-醇通过调控SIRT1/FOXO1信号通路对慢性肾病小鼠肾小管上皮-间质转化的影响OA

Effect of terpinen-4-ol on ameliorating renal tubular epithelial-mesenchy-mal transition via the SIRT1/FOXO1 signaling pathway in chronic kidney disease mice

中文摘要英文摘要

目的:探究松油烯-4-醇通过调控沉默信息调节因子 1(SIRT1)/叉头盒蛋白 O1(FOXO1)信号通路对慢性肾病(CKD)小鼠肾小管上皮-间质转化(EMT)的影响.方法:24 只小鼠随机分为4 组:正常对照组,CKD 模型组,松油烯-4-醇低、高剂量组,每组 6 只.除正常对照组以外其他 3 组建立 CKD 模型.造模成功后,正常对照组和CKD 模型组给予等体积橄榄油灌胃;松油烯-4-醇低、高剂量组分别给予10 和20 mg/kg 松油烯-4-醇灌胃,每 d 灌胃1 次,连续6 周.实验结束后,采集小鼠眼球血,检测血清 BUN 和 Scr 含量;安乐死小鼠后取肾组织,采用 HE 和Masson 染色观察肾组织病理变化,采用 Western blot 检测 E-cadherin、α-SMA、Vimentin、SIRT1 和 FOXO1 蛋白的表达水平.另取36 只小鼠分为 6 组:Lv-NC 组、Lv-NC+CKD 组、Lv-NC+CKD+松油烯-4-醇组、Lv-Sirt1 RNAi 组、Lv-Sirt1 RNAi+CKD 组、Lv-Sirt1 RNAi+CKD+松油烯-4-醇组,每组6 只.CKD 模型的建立及松油烯-4-醇(20 mg/kg)给药方法同上.Lv-NC 组、Lv-NC+CKD 组、Lv-NC+CKD+松油烯-4-醇组小鼠尾静脉注射感染阴性对照的慢病毒,其他3 组注射感染 Sirt1 RNAi 的慢病毒,5×107 U/只,连续 2 周.安乐死小鼠后取肾组织,采用 Western blot 检测E-cadherin、α-SMA、Vimentin、SIRT1 和 FOXO1 蛋白的表达水平,并采用 HE 和 Masson 染色观察肾组织病理变化.结果:松油烯-4-醇可改善 CKD 小鼠的肾功能损伤,下调肾组织中 α-SMA 和 Vimentin 蛋白表达,上调 E-cadherin 及SIRT1、FOXO1 蛋白表达(P<0.05).敲低 Sirt1 表达可加剧 CKD 小鼠肾损伤,进一步上调肾组织 α-SMA 和 Vimen-tin 蛋白表达,下调 E-cadherin 及 SIRT1、FOXO1 蛋白表达(P<0.05),而松油烯-4-醇可逆转此现象(P<0.05).结论:松油烯-4-醇可能通过激活 SIRT1/FOXO1 信号通路影响 EMT,从而改善 CKD 小鼠肾损伤.

Aim:To investigate the effect of terpinen-4-ol on renal tubular epithelial-mesenchymal transition(EMT)in mice with chronic kidney disease(CKD)by regulating the sirtuin 1(SIRT1)/forkhead box O1(FOXO1)signaling pathway.Methods:A total of 24 mice were randomly divided into 4 groups:normal control group,CKD model group,and low and high dose terpinen-4-ol groups,with 6 mice in each group.Except the normal control group,CKD models were established in the other 3 groups.After successful modeling,the normal control group and CKD model group were given equal volumes of olive oil by gavage;low and high dose terpinen-4-ol groups were administered 10 and 20 mg/kg terpinen-4-ol by gavage,respectively,once a day for 6 consecutive weeks.After the experiment,blood samples were collected via retro-orbital puncture and serum BUN and Scr levels were measured;after euthanizing,kidney tissue was taken and observed for pathological changes using HE and Masson staining.Western blot was used to detect the expression levels of E-cadherin,α-SMA,Vimentin,SIRT1,and FOXO1 proteins.Another 36 mice were divided into 6 groups:Lv-NC group,Lv-NC+CKD group,Lv-NC+CKD+terpinen-4-ol group,Lv-Sirt1 RNAi group,Lv-Sirt1 RNAi+CKD group,Lv-Sirt1 RNAi+CKD+terpinen-4-ol group,with 6 mice in each group.The establishment of CKD model and the administration method of terpinen-4-ol(20 mg/kg)were the same as above.Lv-NC group,Lv-NC+CKD group,Lv-NC+CKD+terpinen-4-ol group were administered Lv-NC(5×107 U/mouse)via tail vein injection,while the other3 groups were injected Lv-Sirt1 RNAi(5×107 U/mouse)for2 consecutive weeks.After euth-anizing,kidney tissue was taken and Western blot was used to detect the expression levels of E-cadherin,α-SMA,Vimentin,SIRT1,and FOXO1 proteins.HE and Masson staining were used to observe the pathological changes in kidney tissue.Re-sults:Terpinen-4-ol could improve renal function damage in CKD mice,downregulate the expression levels of α-SMA and Vimentin proteins in renal tissue,and upregulate the expression levels of E-cadherin,SIRT1,and FOXO1 proteins(P<0.05).Knocking down Sirt1 expression can exacerbate kidney damage in CKD mice,further upregulate the expression levels of α-SMA and Vimentin proteins,downregulate the expression levels of E-cadherin,SIRT1,and FOXO1 proteins(P<0.05),while terpinen-4-ol could reverse this phenomenon(P<0.05).Conclusion:Terpinen-4-ol may affect EMT by acti-vating the SIRT1/FOXO1 signaling pathway,thereby improving kidney injury in CKD mice.

何丽;毕俊;王宇庭;肖红;何永祥;张彦燕

黔西市人民医院药剂科 贵州黔西 551500||贵州医科大学天然药物资源优效利用重点实验室 贵阳 561113贵州医科大学天然药物资源优效利用重点实验室 贵阳 561113贵州医科大学天然药物资源优效利用重点实验室 贵阳 561113黔西市人民医院药剂科 贵州黔西 551500黔西市人民医院药剂科 贵州黔西 551500贵州医科大学天然药物资源优效利用重点实验室 贵阳 561113

医药卫生

松油烯-4-醇肾小管上皮-间质转化慢性肾病沉默信息调节因子1叉头盒蛋白O1小鼠

terpinen-4-olrenal tubular epithelial-mesenchymal transitionchronic kidney diseasesirtuin 1forkhead box O1mouse

《郑州大学学报(医学版)》 2026 (4)

45-49,5

国家自然科学基金项目(82060791)贵州省中医药管理局中医药、民族医药科学技术研究项目(QZYY-2025-158)贵州省卫生健康委员会科学技术基金项目(gzwkj2025-543)

10.13705/j.issn.1671-6825.2025.05.190

评论